Apellis Pharmaceuticals Inc

NASDAQ:APLS   3:59:42 PM EDT
45.68
+0.16 (+0.35%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.68B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.5 Million
Adjusted EPS-$1.63
See more estimates
10-Day MA$46.03
50-Day MA$49.38
200-Day MA$38.18
See more pivots

Apellis Pharmaceuticals, Inc. Stock, NASDAQ:APLS

100 Fifth Avenue, Suite A, Waltham, Massachusetts 02451
United States of America
Phone: +1.617.977.5700
Number of Employees: 235

Description

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.